BS
BIO icon

Banco Santander’s Bio-Rad Laboratories Class A BIO Stock Holding History

Banco Santander’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-834
Closed -$316K – 427
2023
Q2 		$316K Hold
834
– – ﹤0.01% 379
2023
Q1 		$400K Sell
834
-999
-55% -$468K 0.01% 312
2022
Q4 		$771K Hold
1,833
– – 0.01% 263
2022
Q3 		$765K Buy
+1,833
New +$914K 0.01% 267
2022
Q2 		– Sell
-4,000
Closed -$2.25M – 375
2022
Q1 		$2.25M Buy
+4,000
New +$2.41M 0.02% 223

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Banco Santander's BIO Position: Q3 2023 in Review

Banco Santander sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2023, closing a stake of 834 shares — an estimated $316K sold.

Banco Santander first reported a position in BIO in Q1 2022 and held it in 5 quarters. The position peaked at $2.25M in Q1 2022. 468 funds tracked by Wall St. Rank hold BIO as of Q3 2023.

  • Banco Santander reported no remaining Bio-Rad Laboratories Class A position as of Q3 2023 after selling out during the quarter.
  • Banco Santander sold 834 Bio-Rad Laboratories Class A shares in Q3 2023, an estimated $316K.
  • Banco Santander first reported a position in Bio-Rad Laboratories Class A in Q1 2022 and held it in 5 quarters.
  • Banco Santander's Bio-Rad Laboratories Class A position peaked at $2.25M in Q1 2022.
  • 468 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2023.

Based on Banco Santander's 13F filing for Q3 2023, filed 8 Nov 2023.